CD274 and non-small cell lung carcinoma: Therefore, we conducted a multicenter, retrospective, real-world study to evaluate the effectiveness and safety of paclitaxel liposome based chemotherapy combined with PD-1/PD-L1 inhibitor in the treatment of patients with advanced NSCLC.